Company intelligence / Profile preview
Pannonpharma Ltd.
- Ownership
- Private
- Employees
- ~28
- Development stage
- Commercial
Overview
Pannonpharma Ltd. is a medium-sized Hungarian pharmaceutical manufacturer with commercialized portfolios in branded generics, traditional herbal medicines, medical devices, and cosmetics. The company has an active R&D program focused on both synthetic pharmaceuticals and plant-based/herbal products. It produces both Rx and OTC products across several therapeutic areas including antivirals, cardiovascular health, pain/inflammation relief, gastrointestinal health, and more. Subsidiary activities include controlled cultivation of medicinal plants for API production.
- Therapeutic areas
- ImmunologyGastroenterologyCardiovascularOphthalmologyNeurologyInfectious Diseases
- Modalities
- Small molecules (branded generics, APIs)Herbal/traditional medicinesMedical devices
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Pannonpharma Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pannonpharma Ltd..